Clinical Management of End-Stage Renal Disease Patients on Dialysis Receiving Radioactive Iodine Treatment

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Rahaf AlSadi ◽  
Landon C. Aziz ◽  
Michael Bohan ◽  
Shaheen Dewji ◽  
Othmane Bouhali ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Clinical Management ◽  
Radioactive Iodine ◽  
Iodine Treatment ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Dosing of radioactive iodine in end-stage renal disease patient with thyroid cancer

2017 ◽  
Vol 2017 ◽  
Author(s):  
Mallika Bhat ◽  
Matty Mozzor ◽  
Savneek Chugh ◽  
Vamsi Buddharaju ◽  
Monica Schwarcz ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Radioactive Iodine ◽  
Disease Patient ◽  
Patient Treatment ◽  
List Type ◽  
Cancer Management ◽  
Stage Renal Disease ◽  
End Stage

Summary We describe detailed administration of thyroidal and extrathyroidal doses of radioiodine to a patient with end-stage renal disease on hemodialysis. A thorough description of area under curve measurements in a patient with compromised renal function has rarely been described in the literature. Few publications have described thyroid cancer management of patients on hemodialysis, and we believe our management will aid in patient treatment in the future. Learning points: Scheduling of hemodialysis is important when administering radioactive iodine. Treatment of thyroid cancer with radioiodine in patients with end-stage renal disease requires multidisciplinary approach coordinating dialysis, nuclear medicine and endocrinologists care. Balancing ideal dosage of I131 and the timing of dialysis to insure maximal thyroidal uptake and minimal extra thyroidal I131 concentration is necessary.

Sign in / Sign up

Export Citation Format

Share Document